ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022

Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 4

Abstract

Objective To investigate the distribution of ABO and RhD blood groups among voluntary blood donors in Guangzhou, in order to ensure clinical blood safety and better serve blood donors. Methods Routine ABO and RhD blood group screening tests were carried out among voluntary blood donors from January 2021 to December 2022. The composition ratio of ABO blood group was statistically analyzed. The samples with discrepancy between forward and reverse blood grouping and negative RhD blood group samples were further verified by serological test to analyze the ABO subtypes and the reasons for missed detection. Results A total of 749 123 blood samples were screened from January 2021 to December 2022, and 513 291 samples were collected after excluding repeat blood donors, with the ABO blood groups as 208 126(40.55%) of O type, 138 859(27.05%) of A type, 130 987(25.52%) of B type and 35 319(6.88%) of AB type. The screening results showed discrepancy between forward and reverse blood grouping in 506 samples, of which 58 were with weak/non-erythrocyte reaction, 16 with erythrocyte reaction, 215 with weak/non-serum reaction, and 217 with serum reaction. Further serological test indicated that 44 samples were ABO subtypes, among which 13 were subtype A, 26 subtype B, 5 subtype AB and 3 B (A) and 14 Bombay-like blood group. The blood group with the highest missed detection rate in repeat blood donors were A3/B3 subtype (68.42%). A total of 128 unexpected antibody positive samples were detected among 513 291 samples A total of 2 277 samples were screened negative for RhD blood type, of which 2 188 were confirmed to be Rh negative (2 188/513 291, 0.43%), 89 were D variants (89/513 291, 0.02%, ) and 30 were detected with unexpected antibodies (30/2 188, 1.37%). Conclusion The ABO blood group distribution of blood donors in Guangzhou is O>A>B>AB, and the proportion of RhD negative population is 0.43%, slightly highter than 0.3%-0.4% of Han population nationwide. The ABO blood group subtype is dominated by B subtype. The detection rate and missed detection rate of A3/B3 subtypes in routine blood group tests are the highest.

Authors and Affiliations

Xuying LIU, Boquan HUANG, Fenfang LIAO, Zhongping LI, Haojian LIANG, Rongsong DU, Junmou XIE, Aiqiong HUANG, Hao WANG

Keywords

Related Articles

Suspected hemolysis caused by type A therapeutic plasma exchange in a patient with AB subtype miss detected

Objective To investigate the serological changes of blood type and whether hemolytic reactions occurred in a patient with ABw subtype after type A therapeutic plasma exchange(TPE) retrospectively. Methods The ABO blood g...

Bone density and bone metabolism in plasmapheresis donors

Objective To investigate the level of serum bone metabolism and biochemical markers and bone density of plasmapheresis donors, and to provide scientific basis for ensuring the health and safety of plasmapheresis donors i...

Risk factors of allergic reactions caused by therapeutic plasma exchange: a single-center analysis

Objective To review the occurrence of allergic reactions during therapeutic plasma exchange (TPE) and to explore the risk factors of TPE allergic reactions. Methods The clinical data of 929 patients treated with TPE usin...

Clinical application of thrombelastogram and reference interval for our laboratory

Objective To respectively analyze the application of thrombogram (TEG) in our hospital and explore the reference interval for our laboratory. Methods Healthy adults who underwent physical examination in our hospital from...

Establishment of an resilience evaluation index framework for blood service system under emergency support

Objective To construct an index framework for the evaluation of blood service system resilience under emergency support, and improve the ability of blood centers to deal with emergencies. Methods The contents of evaluati...

Download PDF file
  • EP ID EP738801
  • DOI 10.13303/j.cjbt.issn.1004-549x.2024.04.011
  • Views 33
  • Downloads 0

How To Cite

Xuying LIU, Boquan HUANG, Fenfang LIAO, Zhongping LI, Haojian LIANG, Rongsong DU, Junmou XIE, Aiqiong HUANG, Hao WANG (2024). ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022. Chinese Journal of Blood Transfusion, 37(4), -. https://europub.co.uk/articles/-A-738801